CLOVERNA Inc.
PrivateLast Round
Pre Seed
Jun 30, 2022
Total Funding Raised
$734,000
Company Overview
CLOVERNA Inc. is a biotechnology company that develops RNA-targeted drug discovery technology to identify therapeutic targets for rare and intractable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CLOVERNA Inc. Comparables
Compare CLOVERNA Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reborna Biosciences, Inc. | 83% | |
| ReviR Therapeutics | 79% | |
| HAYA Therapeutics | 78% | |
CLOVERNA Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jun 30, 2022 |
CLOVERNA Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 114% MoM.
- Mar 2, 2026
Monthly visitors grew 265% MoM, reaching 1.2K.
CLOVERNA Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CLOVERNA Inc.'s valuation, stock price, and market status.